Navigation Links
Molecular Therapy Holds Promise in the Treatment of Amyotrophic Lateral Sclerosis

manageable, chronic disease."

Within a year, Cleveland hopes the first clinical trial will be initiated in humans. In order to deliver the antisense drug directly to the nervous system, surgeons will insert a small pump into a patient using a fairly routine surgery that has already been approved for management of pain. A small catheter is then implanted into the area surrounding the spinal cord, in order to pump antisense oligonucleotide drugs directly into the nervous system.

The investigators noted that if the antisense approach works for ALS – by delivering therapeutic agents for neurodegenerative diseases across the highly impermeable blood-brain barrier – it would likely also work in other neurodegenerative conditions, including Alzheimer's, Parkinson's and Huntington's diseases.

"We know we're on target with the pathogenic mechanism," said Cleveland. The remaining question is whether the genetic-based therapy will be tolerated. "If tolerated, this sets the stage for broader treatment of neurodegenerative disease, especially Huntington's disease, where there is currently no treatment, but key genes involved in promoting disease are known."

Source :Eureka

'"/>




Page: 1 2 3

Related medicine news :

1. Molecular markers for early diagnosis of breast and ovarian cancer
2. Scientists Developed Map For Brain Molecular Communities
3. Molecular Mechanism Of HIV Infecting The Healthy Cells Discovered.
4. Molecular Flaw Detected in Aggressive Breast Cancers
5. Molecular Computer Developed To perform Calculations From Within Human Body
6. Molecular Imaging Of Cancer Now Possible, New Hybrid Virus Produced
7. Molecular Basis Of ALS Found
8. New Molecular Treatment Identified To Treat Blood Cell Cancers
9. Researchers Find Molecular "Brake" to Cell Death
10. Solitons Could Power Molecular Electronics, Artificial Muscles
11. Discovery of Agile Molecular Motors Could Aid in Treating Motor Neuron Diseases

Post Your Comments:
(Date:12/4/2009)...e-USNewswire/ -- The following is an op-ed by Jeff...hropies: ,, Credit Senators John Kerry (D-MA) a...tion to the health care debate: a bill ends a glar...nylketonuria (PKU) control their potentially devas...ious chronic conditions are treated. "The Medical...
(Date:12/4/2009)...Journal of Neurosurgery: Pediatrics finds that op...ocytoma, or JPA, tumors in the thalamus of the bra... or DTI. The sensitivity of DTI imaging allows fo...brain. This information can maximize the potentia...damage to the fiber bundles that are directly rela...
(Date:12/4/2009)...e personality, study finds , , FRIDAY, D...online social network, such as Facebook, reveal th...s a new study, which finds that people tend to exp...ties. , "I was surprised by the findings becau...sing their profiles to promote an enhanced impress...
(Date:12/4/2009)...leading manufacturer of over-the-counter topical c...nsumers’ quality of life, today announced th...ric Medical Association (APMA) Seal of Approval fo.... , (PRWEB) December 4, ...er-the-counter topical cream and first aid product...
(Date:12/4/2009)...ogy company GemaTech launches its new approach to ... Unit (PRU) is a call re-routing solution offered ...s organisations to rapidly re-route their incoming...location, with additional voice recording if desir...ruption . , (PRWEB) Decem...
Breaking Medicine News(10 mins):Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 3Health News:Online Identities Likely to Match Reality 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4Health News:GemaTech Launches Portable Recovery Unit. The Latest Design in Emergency Telecoms Resilience and Continuity 2
...ding,healthcare communication services company, an...m Advisors(TM). Platform Advisors, based in New,Yo...ific consulting,services for pharmaceutical, biote...ionals and commercial strategists.,The integrated ...
...fat molecule have the potential to slow down skin ...esearchers report. , Through both the normal agi...ooth, young skin inevitably becomes coarse and wri...s that chew up existing collagen. , Covering up, ...
...n construction jobs, CDC reports , , THURS...ace a greater risk of dying from work-related inju...nstruction industry, U.S. health officials said Th... deaths in the United States during that time, a h...
...rwent liver transplantation suffered a subsequent ...ed having had biliary-enteric anastomosis (choledo...evious liver or kidney transplant, and more than f...cle is also available online at Wiley Interscience...
...ve Albany Until,Priority Bills are Passed, ALBANY...tive Session, today AARP called upon Governor Pate...mbly Speaker Sheldon Silver to work,together and p... "The 2008 Legislative Session officially ends on...
... and life-saving medicines, purchased online was p...m on Pharmaceutical AntiCounterfeiting(TM) i...n Alliance for Access to,Safe Medicines (EAASM) ha...ed online are fake or substandard. These include,m...
Other Medicine News:Health News:Cline Davis & Mann Launches Platform Advisors(TM), a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pharmaceutical, Biotechnology, and Medical Device Industry 2Health News:Hispanic Workers Dying at Higher Rates Than Others 2Health News:Hispanic Workers Dying at Higher Rates Than Others 3Health News:Researchers determine risk factors for infection after liver transplantation 2Health News:AARP Calls for Action on Top Consumer Priorities 2Health News:Death on the Net? Over 60% of Medicines Sold by Online Pharmacies are Fake 2Health News:Death on the Net? Over 60% of Medicines Sold by Online Pharmacies are Fake 3
(Date:12/3/2009)...ISON, N.J., Dec. 3 A gen...of developing a potentially life-threatening blood...rapies or chemicals is one of several medical disc...est Diagnostics (NYSE: DGX ) will present during...ual Meeting and Exposition, December 5-8, 2009, in...
(Date:12/3/2009)...ILMINGTON, Del., Dec. 3 ParagonRx,...utical risk management and optimal medication use,... the FDA,s draft guidance on REMS - Risk Evaluatio...ons for REMS lifecycle management. Dr. Gary Slatk...t on REMS and risk management programs, will lead ...
(Date:12/3/2009)...N DIEGO, Dec. 3 Cardium ...at its wholly-owned subsidiary, Tissue Repair Comp...ing with the U.S. Food and Drug Administration (FD...TM) product candidate based on positive data from...clinical study. Today,s submission with the FDA c...
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5First 5 California Approves 2481 4 Million Contribution to Help Restore Healthy Families Programs Viability 54507 1First 5 California Approves 2481 4 Million Contribution to Help Restore Healthy Families Programs Viability 54507 2Some Birth Control Pills Safer Than Others 54505 1Some Birth Control Pills Safer Than Others 54505 2Some Birth Control Pills Safer Than Others 54505 3Chiropractors Focus on Patients Best Interest 54503 1
...ersome" vaginal atrophy, symptoms among sexually...women; results presented today at 19th Annual Nort...ciety Meeting, ANN ARBOR, Mich., Sept. 24 Additi...pemifene tablets) for the treatment of,symptoms of...n showed that,Ophena(TM) significantly improves a ...
...to Raise Awareness about,the Importance of Clinica...News facts:, -- Most Americans with cancer woul...rials if they knew about them. -- In a surve... unaware or unsure that participation in ...ive percent said they would have been willing to e...
Other Medicine Technology:QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 2QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 3QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 4Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs 2Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs 3
...VA for CELL-DYN are assayed linearity control kits... patient reportable range of three- and five-part ...linear performance of the analyzer. CVA and CVA fo... for each instrument model and provide instrument-...
LATITUDE® Patient Management System
...tary EX.P.R.T. Release Technology essentially elim... stent shortening,, Unique anatomically des...bifurcation,, 0.014 Rapid Exchange catheter...matic tip,, Radiopaque marker on catheter c...
...s a whole blood hematology control manufactured sp...d the Coulter AcT5diff instruments. The compositio...rential, positioning the populations within the li...oduct offers 105-day closed-vial stability and 14-...
Medicine Products: